SpiroChem Acquires Cyclenium Pharma to Strengthen its Portfolio in Macrocyclic Therapeutics
(WorldFrontNews Editorial):- Basel, Basel-Stadt Jun 6, 2023 (Issuewire.com) – SpiroChem, an Elite Contract Research Organization (CRO) headquartered in Basel, Switzerland, announced the acquisition of Cyclenium Pharma, a…
